Hepatitis B Vaccination, Screening, and Linkage to Care

Ann Intern Med. 2018 Jun 19;168(12):902-903. doi: 10.7326/L18-0101.

Authors

Winston E Abara¹, Amir Qaseem², Sarah Schillie¹, Brian J McMahon³, Aaron M Harris¹

Affiliations

¹ Centers for Disease Control and Prevention, Atlanta, Georgia (W.E.A., S.S., A.M.H.).
² American College of Physicians, Philadelphia, Pennsylvania (A.Q.).
³ Alaska Native Tribal Health Consortium and Centers for Disease Control and Prevention, Anchorage, Alaska (B.J.M.).

PMID: 29913503
DOI: 10.7326/L18-0101

No abstract available

Publication types

Letter
Comment

MeSH terms

Centers for Disease Control and Prevention, U.S.
Hepatitis B Surface Antigens
Hepatitis B*
Humans
Mass Screening
United States
Vaccination

Substances

Hepatitis B Surface Antigens